Regulus Therapeutics reported $8K in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Alnylam Pharmaceuticals ALNY:US USD 237.96M 53.45M
AstraZeneca AZN:LN USD 11.25B 1.19B
Astrazeneca AZN:US USD 11.25B 1.19B
Biogen BIIB:US USD 2.14B 152.2M
Celldex Therapeutics CLDX:US USD 347K 158K
Gilead Sciences GILD:US USD 4.78B 423M
GlaxoSmithKline GSK:LN GBP 7.46B 636M
Intercept Pharmaceuticals ICPT:US USD 26.86M 694K
Intrexon XON:US USD 13.8M 11.35M
Lexicon Pharmaceuticals LXRX:US USD 28K 11K
Ligand Pharmaceuticals LGND:US USD 35.04M 30.92M
Sangamo Biosciences SGMO:US USD 4.47M 574K
Spectrum Pharmaceuticals SPPI:US USD 586K 22K
Takeda 4502:JP JPY 779.87B 20.66B
Vital Therapies VTL:US USD 296K 55K
YTE INCY:US USD 644.88M 26.69M